ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, Paige E., Cirrito, John R., Wesson, Daniel W., Lee, C. Y. Daniel, Karlo, J. Colleen, Zinn, Adriana E., Casali, Brad T., Restivo, Jessica L. +5 more·2012·Science

DOI 10.1126/science.1217697

Cited by (1,000)

Items 201–300 of 1,000

Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
Samridhi Sharma, Ting Shen, Nitin Chitranshi, Veer Gupta, Devaraj K. Basavarajappa, Soumalya Sarkar, Mehdi Mirzaei, Yuyi You, Wojciech Krężel, Stuart L. Graham et al. · 2022 · Molecular Neurobiology
Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice
Hisham Qosa, Loqman A. Mohamed, Yazan S. Batarseh, Saeed Alqahtani, Baher A. Ibrahim, Harry LeVine, Jeffrey N. Keller, Amal Kaddoumi · 2015 · The Journal of Nutritional Biochemistry
Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
N. Nalivaeva, N. Belyaev, Caroline Kerridge, A. Turner · 2014 · Frontiers in Aging Neuroscience
Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer’s Disease
Vicent Bonet-Costa, Vicente Herranz‐Pérez, M. Carmen Blanco-Gandía, Cristina Mas‐Bargues, Marta Inglés, Patricia García-Tárraga, Marta Rodríguez‐Arias, José Miñarro, Consuelo Borrás, José Manuel García‐Verdugo et al. · 2016 · Journal of Alzheimer s Disease
Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
Juvenal A. Ríos, Pedro Cisternas, Marco A. Arrese, Salesa Barja Y., Nibaldo C. Inestrosa · 2014 · Progress in Neurobiology
Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
M. F. Uchoa, V. Moser, Christian J. Pike · 2016 · Frontiers in neuroendocrinology (Print)
Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
Angela J. Hanson, Jennifer L. Bayer-Carter, Pattie S. Green, Thomas Jude Montine, Charles W. Wilkinson, Laura D. Baker, G. Stennis Watson, Laura M. Bonner, Maureen Callaghan, James B. Leverenz et al. · 2013 · JAMA Neurology
Impact of Apolipoprotein E on Alzheimer’s Disease
Paul S. Hauser, Robert O. Ryan · 2013 · Current Alzheimer Research
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
Hongqi Yang, Zhikun Sun, Shengdi Chen · 2012 · Translational Neurodegeneration
Unsupervised excitation: GABAergic dysfunctions in Alzheimer’s disease
Eleonora Ambrad Giovannetti, Martin Fuhrmann · 2018 · Brain Research
Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice
Chaoyun Li, Caroline Zug, Hongchun Qu, Hermann J. Schluesener, Zhiyuan Zhang · 2014 · Behavioural Brain Research
Lipid metabolism in Alzheimer’s disease
Liu, Qiang, Zhang, Juan · 2014 · Neuroscience Bulletin
Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARγ/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats
Yuchun Zuo, Lei Huang, Budbazar Enkhjargal, Weilin Xu, Umut Ocak, Zachary D. Travis, Guangyu Zhang, Jiping Tang, Fei Liu, John H. Zhang · 2019 · Journal of Neuroinflammation
Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
Nathalie Pierrot, Donatienne Tyteca, Ludovic D’Auria, Ilse Dewachter, Philippe L. Gailly, Aurélie Hendrickx, Bernadette Tasiaux, Laetitia El Haylani, Nathalie Muls, Francisca N’Kuli et al. · 2013 · EMBO Molecular Medicine
Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease
Judes Poirier, Justin Miron, Cynthia Picard, Patrick Gormley, Louise Théroux, John C.S. Breitner, Doris Dea · 2014 · Neurobiology of Aging
Nurr1 (NR4A2) regulates Alzheimer’s disease‐related pathogenesis and cognitive function in the 5XFAD mouse model
Minho Moon, Eun Sun Jung, Seong Gak Jeon, Moon-Yong Cha, Yongwoo Jang, Woori Kim, Claúdia Lopes, Inhee Mook‐Jung, Kwang‐Soo Kim · 2018 · Aging Cell
Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
Zhang, Can, Griciuc, Ana, Hudry, Eloise, Wan, Yu, Quinti, Luisa, Ward, Joseph, Forte, Angela M., Shen, Xunuo, Ran, ChongZhao, Elmaleh, David R. et al. · 2018 · Scientific Reports
Cancer and Dementia
Mary Ganguli · 2015 · Alzheimer Disease & Associated Disorders
The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease
Moutinho, Miguel, Puntambekar, Shweta S., Tsai, Andy P., Coronel, Israel, Lin, Peter B., Casali, Brad T., Martinez, Pablo, Oblak, Adrian L., Lasagna-Reeves, Cristian A., Lamb, Bruce T. et al. · 2022 · Science Translational Medicine
Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease
Mariani, M. M., Malm, T., Lamb, R., Jay, T. R., Neilson, L., Casali, B., Medarametla, L., Landreth, G. E. · 2017 · Scientific Reports
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
Sophie K. Stukas, Jérôme Robert, Cheryl Lea Wellington · 2014 · Cell Metabolism
ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain
YuHong Fu, Jen-Hsiang T. Hsiao, George Paxinos, Glenda Margaret Halliday, Woojin Scott Kim · 2016 · Journal of Alzheimer s Disease
Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene
Ruiz, A, Heilmann, S, Becker, T, Hernández, I, Wagner, H, Thelen, M, Mauleón, A, Rosende-Roca, M, Bellenguez, C, Bis, J C et al. · 2014 · Translational Psychiatry
Pathway-based drug repositioning using causal inference
Jiao Li, Zhiyong Lu · 2013 · BMC Bioinformatics
Total ApoE and ApoE4 Isoform Assays in an Alzheimer's Disease Case-control Study by Targeted Mass Spectrometry (n = 669): A Pilot Assay for Methionine-containing Proteotypic Peptides
Simon, Romain, Girod, Marion, Fonbonne, Catherine, Salvador, Arnaud, Clément, Yohann, Lantéri, Pierre, Amouyel, Philippe, Lambert, Jean Charles, Lemoine, Jérôme · 2012 · Molecular & Cellular Proteomics
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, John M., Goate, Alison, Masters, Colin L., Cairns, Nigel J., Danek, Adrian, Graff-Radford, Neill, Ghetti, Bernardino, Morris, John C. · 2014 · Current Neurology and Neuroscience Reports
Guggulsterone and bexarotene induce secretion of exosome‐associated breast cancer resistance protein and reduce doxorubicin resistance in MDA‐MB ‐231 cells
Ji Na Kong, Qian He, Guanghu Wang, Somsankar Dasgupta, Michael B. Dinkins, Gu Zhu, Austin Kim, Stefka D. Spassieva, Erhard Bieberich · 2015 · International Journal of Cancer
The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration
Derk, Julia, MacLean, Michael, Juranek, Judyta, Schmidt, Ann Marie · 2018 · Journal of Alzheimer’s Disease & Parkinsonism
Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?
Juan Manuel Zolezzi, Carmen Silva-Álvarez, Daniela Ordenes, Juan Alejandro Godoy, Francisco J. Carvajal, Manuel J. Santos, Nibaldo C. Inestrosa · 2013 · PLoS ONE
Bexarotene Enhances Macrophage Erythrophagocytosis and Hematoma Clearance in Experimental Intracerebral Hemorrhage
Che-Feng Chang, Jordan Massey, Artem Osherov, Luís Henrique Angenendt da Costa, Lauren Hachmann Sansing · 2019 · Stroke
Nuclear receptors in neurodegenerative diseases
Skerrett, Rebecca, Malm, Tarja, Landreth, Gary · 2014 · Neurobiology of Disease
Probing the Sources of the Apparent Irreproducibility of Amyloid Formation: Drastic Changes in Kinetics and a Switch in Mechanism Due to Micellelike Oligomer Formation at Critical Concentrations of IAPP
Jeffrey Brender, Janarthanan Krishnamoorthy, Michele F. M. Sciacca, Subramanian Vivekanandan, Luisa D’Urso, Jennifer Chen, Carmelo La Rosa, Ayyalusamy Ramamoorthy · 2015 · The Journal of Physical Chemistry B
Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo
Leon M. Tai, Kevin P. Koster, Jia Luo, Sue Lee, Yue‐ting Wang, Nicole C. Collins, Manel Ben Aissa, Gregory R. J. Thatcher, Mary Jo LaDu · 2014 · Journal of Biological Chemistry
ABC Transporters Are Key Players in Alzheimer’s Disease
Cátia D. Pereira, Filipa Martins, Jens Wiltfang, Odete A. B. da Cruz e Silva, Sandra Rebelo · 2017 · Journal of Alzheimer s Disease
Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches
Yu-Ying Sun, Zhun Wang, Han‐Chang Huang · 2023 · Cellular and Molecular Neurobiology
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
Vadivel Parthsarathy, Paula L. McClean, Christian Hölscher, Mark Taylor, Claire L. Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini et al. · 2013 · PLoS ONE
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism
Xin Zhou, Chenxi He, Jiangong Ren, Congxin Dai, Sharon R. Stevens, Qianghu Wang, Daniel B. Zamler, Takashi Shingu, Liang Yuan, Chythra R. Chandregowda et al. · 2020 · Journal of Clinical Investigation
Tamibarotene: A Candidate Retinoid Drug for Alzheimer’s Disease
Fukasawa, Hiroshi, Nakagomi, Madoka, Yamagata, Naoko, Katsuki, Hiroshi, Kawahara, Kohichi, Kitaoka, Kazuyoshi, Miki, Takami, Shudo, Koichi · 2012 · Biological and Pharmaceutical Bulletin
Absolute 10-year risk of dementia by age, sex and <i>APOE</i> genotype: a population-based cohort study
Rasmussen, Katrine L., Tybjærg-Hansen, Anne, Nordestgaard, Børge G., Frikke-Schmidt, Ruth · 2018 · Canadian Medical Association Journal
Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors
Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer · 2012 · Journal of Alzheimer s Disease
A Review: Treatment of Alzheimer’s Disease Discovered in Repurposed Agents
Brian Stephen Appleby, Dimitrios A. Nacopoulos, Nicholas J. Milano, Kate Zhong, Jeffrey L. Cummings · 2013 · Dementia and Geriatric Cognitive Disorders
Retinoids as potential targets for Alzheimer's disease
Rupinder Kaur Sodhi, Nirmal Singh · 2014 · Pharmacology Biochemistry and Behavior
PPAR Agonists as Therapeutics for CNS Trauma and Neurological Diseases
Shweta Mandrekar-Colucci, Andrew D. Sauerbeck, Phillip G. Popovich, Dana M. McTigue · 2013 · ASN NEURO
Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes
Motoko Maekawa, A Watanabe, Yoshimi Iwayama, Tetsuya Kimura, Kei Hamazaki, Shabeesh Balan, H Ohba, Yasuko Hisano, Yayoi Nozaki, Tetsuo Ohnishi et al. · 2017 · Translational Psychiatry
A statistical definition for reproducibility and replicability
Prasad Patil, Roger D. Peng, Jeffrey T. Leek · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration
Kuszczyk, Magdalena A., Sanchez, Sandrine, Pankiewicz, Joanna, Kim, Jungsu, Duszczyk, Malgorzata, Guridi, Maitea, Asuni, Ayodeji A., Sullivan, Patrick M., Holtzman, David M., Sadowski, Martin J. · 2013 · The American Journal of Pathology
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
Rebecca Skerrett, Mateus Paquesse Pellegrino, Brad T. Casali, Laura Taraboanta, Gary E. Landreth · 2015 · Journal of Biological Chemistry
Alternative retinoid X receptor (RXR) ligands
Wojciech Krężel, Ralph Rühl, Ángel R. de Lera · 2019 · Molecular and Cellular Endocrinology
Brain Aging and AD-Like Pathology in Streptozotocin-Induced Diabetic Rats
Jianqin Wang, Jie Yin, Yanfeng Song, Lang Zhang, Ying-Xiang Ren, Degui Wang, Li‐Ping Gao, Yuhong Jing · 2014 · Journal of Diabetes Research
Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease
Wilfred Arthur Jefferies, Katherine Ann Price, Kaan E. Biron, Franz Fenninger, Cheryl G. Pfeifer, Dara L. Dickstein · 2013 · Alzheimer s Research & Therapy
Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
Sudip Dhakal, Naufal Kushairi, Chia‐Wei Phan, Benu Adhikari, Vikineswary Sabaratnam, Ian George Macreadie · 2019 · International Journal of Molecular Sciences
Emerging Therapeutics for Alzheimer's Disease
Karen Chiang, Edward H. Koo · 2014 · The Annual Review of Pharmacology and Toxicology
Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots
Shao-Hua Yang, Wenjun Li, Nathalie Sumien, Michael J. Forster, James W. Simpkins, Ran Liu · 2015 · Progress in Neurobiology
Mitochondrial therapeutic interventions in Alzheimer’s disease
Vo Van Giau, Seong Soo A. An, John Hulme · 2018 · Journal of the Neurological Sciences
Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia
Eric E. Abrahamson, Miloš D. Ikonomović · 2020 · Experimental Neurology
Improvement of spatial learning by facilitating large-conductance calcium-activated potassium channel with transcranial magnetic stimulation in Alzheimer's disease model mice
Furong Wang, Yu Zhang, Li Wang, Peng Sun, Xianwen Luo, Yasuhito Ishigaki, Tokio Sugai, Ryo Yamamoto, Nobuo Kato · 2015 · Neuropharmacology
Apolipoproteins E and J interfere with amyloid‐beta uptake by primary human astrocytes and microglia in vitro
Sandra D. Mulder, Henrietta M. Nielsen, Marinus A. Blankenstein, Piet Eikelenboom, Robert Veerhuis · 2014 · Glia
Plasma levels of apolipoprotein E, <i>APOE</i> genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
Rasmussen, Katrine L, Tybjærg-Hansen, Anne, Nordestgaard, Børge G, Frikke-Schmidt, Ruth · 2019 · European Heart Journal
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice
Marguerite Prior, Richard Dargusch, Jennifer L. Ehren, Chandramouli Chiruta, David A. Schubert · 2013 · Alzheimer s Research & Therapy
Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease
Steffany A. L. Bennett, Nicolas Valenzuela, Hongbin Xu, Bettina Franko, Stephen Fai, Daniel Figeys · 2013 · Frontiers in Physiology
Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers
Jason E. Pitt, Kyle C. Wilcox, Vanessa Tortelli, Luan Pereira Diniz, Maira S. Oliveira, Cassandra Dobbins, Xiaowen Yu, Sathwik Nandamuri, Flávia Carvalho Alcântara Gomes, Nadia DiNunno et al. · 2017 · Molecular Biology of the Cell
Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice
Xilin Zhang, Jin Hu, Li Zhong, Na Wang, Longyu Yang, Chia‐Chen Liu, Huifang Li, Xin Wang, Ying Zhou, Yun‐wu Zhang et al. · 2016 · Neuropharmacology
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
LaClair, Katherine D, Manaye, Kebreten F, Lee, Dexter L, Allard, Joanne S, Savonenko, Alena V, Troncoso, Juan C, Wong, Philip C · 2013 · Molecular Neurodegeneration
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu · 2020 · JCI Insight
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases
P. Xu, Da-Bing Li, Xiaotong Tang, Xiaohang Bao, Jing Huang, Yong-Ping Tang, Yang Yang, Haiwei Xu, Xiao-Tang Fan · 2013 · Molecular Neurobiology
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
Athanasios D. Spathis, Xenophon Asvos, Despina Ziavra, Theodoros Karampelas, Stavros Topouzis, Zoe Cournia, Xiaobing Qing, Pavlos Alexakos, Lisa M. Smits, Christina Dalla et al. · 2017 · Proceedings of the National Academy of Sciences
Alzheimer’s disease: Neurotransmitters of the sleep-wake cycle
Jan Van Erum, Debby Van Dam, Peter Paul De Deyn · 2019 · Neuroscience & Biobehavioral Reviews
Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers
Francesco Simone Ruggeri, Johnny Habchi, Sean Chia, Robert I. Horne, Michele Vendruscolo, Tuomas P. J. Knowles · 2021 · Nature Communications
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Waqar Ahmad · 2012 · Molecular Neurobiology
Potential Therapeutic Strategies for Alzheimer’s Disease Targeting or Beyondβ-Amyloid: Insights from Clinical Trials
Qiutian Jia, Yulin Deng, Hong Qing · 2014 · BioMed Research International
Microvascular Alterations in Alzheimer's Disease
Joe Steinman, Hong‐Shuo Sun, Zhong‐Ping Feng · 2021 · Frontiers in Cellular Neuroscience
Amyloid β inhibits retinoic acid synthesis exacerbating A lzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist
Maria Beatriz C.V. Goncalves, Earl E. Clarke, Carl Hobbs, Tony Malmqvist, Robert M. J. Deacon, Julian Jack, Jonathan P. T. Corcoran · 2013 · European Journal of Neuroscience
Alzheimer’s and ABC transporters — new opportunities for diagnostics and treatment
Jens Pahnke, Oliver Langer, Markus Krohn · 2014 · Neurobiology of Disease
Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade
Huntington Potter, Thomas Wısnıewskı · 2012 · International Journal of Alzheimer s Disease
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
William James Deardorff, George Thomas Grossberg · 2016 · Expert Review of Neurotherapeutics
Microglia and Synapse: Interactions in Health and Neurodegeneration
Šišková, Zuzana, Tremblay, Marie-Ève · 2013 · Neural Plasticity
20-Year prevalence projections for dementia and impact of preventive policy about risk factors
Hélène Jacqmin‐Gadda, Annick Alpérovitch, Claire Montlahuc, Daniel Commenges, Karen Leffondré, Carole Dufouil, Alexis Elbaz, Christophe Tzourio, Joël Ménard, Jean‐François Dartigues et al. · 2013 · European Journal of Epidemiology
Photodegradation of β-sheet amyloid fibrils associated with Alzheimer's disease by using polyoxometalates as photocatalysts
Meng Li, Can Xu, Jinsong Ren, Enbo Wang, Xiaogang Qu · 2013 · Chemical Communications
ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease
Yassine, Hussein N., Feng, Qingru, Chiang, Jiarong, Petrosspour, Larissa M., Fonteh, Alfred N., Chui, Helena C., Harrington, Michael G. · 2016 · Journal of the American Heart Association
Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Brian Stephen Appleby, Jeffrey L. Cummings · 2013 · Current Topics in Medicinal Chemistry
Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation
Malm, Tarja, Mariani, Monica, Donovan, Lauren J, Neilson, Lee, Landreth, Gary E · 2015 · Journal of Neuroinflammation
Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ
Zhishen Xie, Jianping Zhao, Hui Wang, Yali Jiang, Qiaoling Yang, Yu Fu, Huahui Zeng, Christian Hölscher, Jiangyan Xu, Zhenqiang Zhang · 2020 · Biomedicine & Pharmacotherapy
Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease
Lisa M. McGinley, Erika Sims, J. Simon Lunn, Osama Nezar Kashlan, Kevin S. Chen, Elizabeth S. Bruno, Crystal M. Pacut, Tom Hazel, Karl K. Johe, Stacey A. Sakowski et al. · 2016 · Stem Cells Translational Medicine
Remembering your A, B, C's: Alzheimer's disease and ABCA1
Lewandowski, Cutler T., Laham, Megan S., Thatcher, Gregory R.J. · 2022 · Acta Pharmaceutica Sinica B
Autophagy Induction by Bexarotene Promotes Mitophagy in Presenilin 1 Familial Alzheimer’s Disease iPSC-Derived Neural Stem Cells
Patricia Martín-Maestro, Andrew A. Sproul, Héctor Martínez, Dominik Paquet, Meri Gerges, Scott Noggle, Anatoly A. Starkov · 2019 · Molecular Neurobiology
The roles of liver X receptor α in inflammation and inflammation‐associated diseases
Lin Zhao, Wangrui Lei, Chao Deng, Zhen Biao Wu, Meng Sun, Zhenxiao Jin, Yanbin Song, Zhi Ping Yang, Shuai Jiang, Mingzhi Shen et al. · 2020 · Journal of Cellular Physiology
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals
Rasmussen, Katrine L., Tybjærg‐Hansen, Anne, Nordestgaard, Børge G., Frikke‐Schmidt, Ruth · 2018 · Alzheimer's & Dementia
Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales
Ian A. Clark, Craig Atwood, Richard L. Bowen, Gilberto Paz-Filho, Bryce Vissel · 2012 · Pharmacological Reviews
Genome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration
Radosveta P. Koldamova, Jonathan Schug, Martina I. Lefterova, Andrea A. Cronican, Nicholas Francis Fitz, Faith A. Davenport, Alexis Carter, Emilie L. Castranio, Iliya M. Lefterov · 2013 · Neurobiology of Disease
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease
Miguel Moutinho, Gary E. Landreth · 2017 · Journal of Lipid Research
Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid
Heinsinger, Nicolette Mary, Gachechiladze, Mariam Alexandra, Rebeck, G. William · 2016 · Journal of Neuropathology & Experimental Neurology
Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity.
Ping Zhang, Fei Wang, Jianying Hu · 2014 · PubMed Central
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s Disease
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Arun Kumar, Md. Sahab Uddin, SIMONA GABRIELA BUNGAU · 2020 · Molecular Neurobiology
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Maroua Jalouli, Md. Ataur Rahman, Philippe Jeandet, Tapan Behl, Athanasios T. Alexiou, Ghadeer Mohsen Albadrani, Mohamed M. Abdel‐Daim, Asma Perveen et al. · 2021 · Current Neuropharmacology
Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer’s disease (AD)
Walter J. Lukiw · 2012 · Expert Opinion on Emerging Drugs
Response to Comments on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”
Gary E. Landreth, Paige E. Cramer, Mitchell M. Lakner, John R. Cirrito, Daniel W. Wesson, Kurt R. Brunden, Donald A. Wilson · 2013 · Science
Apolipoprotein E associated with reconstituted high‐density lipoprotein‐like particles is protected from aggregation
Hubin, Ellen, Verghese, Philip B., van Nuland, Nico, Broersen, Kerensa · 2019 · FEBS Letters
Inverse Correlation Between Alzheimer’s Disease and Cancer: Short Overview
Agnieszka Zabłocka, Wioletta Kazana, Marta Sochocka, Bartłomiej Stańczykiewicz, Maria Janusz, Jerzy Leszek, Beata Orzechowska · 2021 · Molecular Neurobiology
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
S. Saito, M. Ihara · 2014 · Frontiers in Aging Neuroscience
Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor/Retinoic Acid Receptor Pathway
Jing Zhao, Yuan Fu, Chia‐Chen Liu, Mitsuru Shinohara, Henrietta M. Nielsen, Qiang Dong, Takahisa Kanekiyo, Guojun Bu · 2014 · Journal of Biological Chemistry